Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture

NCT06658379 · clinicaltrials.gov ↗
RECRUITING
Status
640
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Charite University, Berlin, Germany

Collaborators